Literature DB >> 3544995

Sleep disorders: sleep apnea and narcolepsy.

A Kales, A Vela-Bueno, J D Kales.   

Abstract

Symptoms of obstructive sleep apnea, a potentially life-threatening disorder, include excessive daytime sleepiness and sleep attacks, nocturnal breath cessation, and snorting and gasping sounds. These symptoms usually become manifest before age 40 and cluster within a few years. Most patients are obese, hypertensive men who eventually develop cardiovascular abnormalities. If sleep apnea is suspected based on clinical information, a sleep laboratory evaluation is indicated. For severe obstructive sleep apnea, tracheostomy is the most effective treatment. Narcolepsy, another sleep disorder, is a life-long and usually disabling condition. In most narcoleptic patients the first symptoms develop during childhood or adolescence, yet many years pass before the proper diagnosis is made. The presence of sleep attacks together with auxiliary symptoms, particularly cataplexy, is diagnostic. Treatment of narcolepsy includes stimulants in combination with therapeutic naps for sleep attacks and tricyclic drugs for cataplexy.

Entities:  

Mesh:

Year:  1987        PMID: 3544995     DOI: 10.7326/0003-4819-106-3-434

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  10 in total

1.  Comparison of clinical features and polysomnographic findings between men and women with sleep apnea.

Authors:  Shiho Yamakoshi; Takatoshi Kasai; Yasuhiro Tomita; Hisashi Takaya; Satoshi Kasagi; Masateru Kawabata; Koji Narui; Yasuhiro Setoguchi
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

Review 2.  Cardiovascular function during sleep apnoeas.

Authors:  E D Vlachogianni
Journal:  Postgrad Med J       Date:  1989-02       Impact factor: 2.401

3.  Multiple sleep pathologies presenting as depression.

Authors:  J A Fleming; R B Warneboldt
Journal:  Can Fam Physician       Date:  1990-06       Impact factor: 3.275

4.  Adult obstructive sleep apnea with secondary enuresis.

Authors:  M A Brown; M B Jacobs; R Pelayo
Journal:  West J Med       Date:  1995-11

5.  The laboratory evaluation of sleep and its disorders.

Authors:  J A Fleming
Journal:  Can Fam Physician       Date:  1988-02       Impact factor: 3.275

Review 6.  Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update.

Authors:  F Lanfranco; G Motta; M A Minetto; E Ghigo; M Maccario
Journal:  J Endocrinol Invest       Date:  2010-03       Impact factor: 4.256

7.  The veteran population: one at high risk for sleep-disordered breathing.

Authors:  María Elena Ocasio-Tascón; Edwin Alicea-Colón; Alfonso Torres-Palacios; William Rodríguez-Cintrón
Journal:  Sleep Breath       Date:  2006-06       Impact factor: 2.816

8.  Cost-effectiveness of oral appliances in the treatment of obstructive sleep apnoea-hypopnoea.

Authors:  Mohsen Sadatsafavi; Carlo A Marra; Najib T Ayas; John Stradling; John Fleetham
Journal:  Sleep Breath       Date:  2009-02-20       Impact factor: 2.816

9.  Beneficial effect of inhaled CO2 in a patient with non-obstructive sleep apnoea.

Authors:  P M Villiger; C W Hess; W H Reinhart
Journal:  J Neurol       Date:  1993-11       Impact factor: 4.849

10.  Narcolepsy: current treatment options and future approaches.

Authors:  Michel Billiard
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.